Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06016127 · ClinicalTrials.gov registry record · NA
Cryoneurolysis for Facet Mediated Chronic Low Back Pain
A NA study of Low Back Pain and Facet Joint Pain, sponsored by Medical Pain Management Services, P.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06016127: Completed NA study of Low Back Pain and Facet Joint Pain, sponsored by Medical Pain Management Services, P.
NCT06016127 is a NA study of Low Back Pain and Facet Joint Pain that has completed, run by Medical Pain Management Services, P. The registered enrollment target is 30 participants, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06016127, a NA study of Low Back Pain and Facet Joint Pain, has completed, sponsored by Medical Pain Management Services, P.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, randomized, pilot study in adult subjects with facet mediated CLBP. Thirty (30) subjects are planned for initial enrollment and will be randomized 1:1 to receive ioveraº medial branch cryoneurolysis or radiofrequency ablation.
Primary Outcome
Safety will be assessed as the number of subjects with reported treatment-related adverse related to cryoneurolysis or RFA.
Conditions Studied
Interventions
- DEVICE iovera system
- DEVICE Radiofrequency ablation
Study Locations (1)
New York
- The Albany & Saratoga Centers For Pain Management - Saratoga Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-06-18 |
| Est. Completion | 2023-10-23 |
| Phase | NA |
What the finished NCT06016127 record still lists
NCT06016127 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which iovera system is the first listed.
NCT06016127 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06016127 about?
NCT06016127 is a clinical study titled "Cryoneurolysis for Facet Mediated Chronic Low Back Pain". This is a single-center, randomized, pilot study in adult subjects with facet mediated CLBP. Thirty (30) subjects are planned for initial enrollment and will be randomized 1:1 to receive ioveraº medial branch cryoneurolysis or radiofrequency ablation.
What is the current status of trial NCT06016127?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-06-18. Estimated completion is 2023-10-23.
What conditions does trial NCT06016127 study?
This clinical trial studies the following conditions: Low Back Pain, Facet Joint Pain.
What interventions are being tested in trial NCT06016127?
The interventions under investigation include: iovera system (DEVICE), Radiofrequency ablation (DEVICE).
Who is sponsoring clinical trial NCT06016127?
This trial is sponsored by Medical Pain Management Services, P, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06016127 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06016127's enrollment target sits among peer trials
30 106th of 122 higher than 13 of 122 other Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Erector Spinae Plane Block for Acute Back Pain in the Emergency Department
RECRUITING · NA
-
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy
RECRUITING · NA
-
Ischemic Preconditioning in Osteoarthritis and Back Pain
RECRUITING · NA
-
Feasibility of Identifying Brain Mechanisms of Qigong and Behavioral Outcomes After Qigong Practice in People With Chronic Low Back Pain
RECRUITING · NA
-
Neural Mechanisms of Meditation for Opioid-Treated Chronic Low Back Pain
RECRUITING · NA
-
Perspectives on Spinal Manipulative Therapy for Low Back Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI